Table of Contents
| << Previous Issue | Dec 2002 (Vol: 2002, Issue: 31) | Next Issue >> |
- Section: Company Profile
-
BioXell SpA
- Section: Distribution & Marketing
-
Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care
-
LG Life Sciences to Market Thymitaq® in Republic of Korea
- Section: General
-
Roche’s Option on Antisoma
-
Deal Making in the Drug Delivery Sector
-
Technology Focus: PEGylation
- Section: Licensing
-
CeNeS Licenses MS Treatment to Acorda
-
Roche Secured Option on Antisoma Pipeline
-
AlphaRx to License Anticancer Toxin from Select Therapeutics
-
Allergan Licenses Phase I Skin Cancer Drug from Peplin
- Section: Mergers & Acquisitions
-
Lundbeck Strengthens CNS Research Through Acquisition of Synaptic
- Section: Research & Development
-
Millennium Initiates Cardiovascular Collaboration with The Cleveland Clinic
-
Cell Therapeutics Researches Oncology Targets with Hope Heart Institute
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS